RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Vortioxetine Improves Cognitive Function, Lessens Symptoms of Major Depression
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 8
SP 14
OP 15
DO 10.1177/155989771408005
UL http://mdc.sagepub.com/content/14/8/14.abstract
AB A multinational, randomized, double-blind, placebo-controlled Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder (MDD) [FOCUS; NCT01422213] has demonstrated the drug's efficacy in improving cognitive function and lessening depression symptoms [APA 2014 (poster NR6-114)].